Pharma endeavours to drive positive action from patient insights. Read to find out how they could improve their methodologies and outcomes.

RWD for rare diseases is scarce, but pharma can work to leverage existing processes and build trust to enhance the scope of available data.

Generics and biosimilars are crucial to healthcare worldwide, but there are challenges in getting these medicine to patients.

The challenges faced by the transgender community are vast, but pharma has the power to drive better health equity. Read more.

With Moderna pledging not to enforce its COVID-19 vaccine patent in 92 LMICs, a hub in South Africa is pushing ahead with replication. Read for more details.

The pandemic has exacerbated already troubling trends in the market access but has also created an opportunity for change in how drugs are priced and procured.

Pharma is making great strides in tackling climate change, but more needs to be done to meet net zero targets.

Why is the purpose and value of medical affairs sometimes poorly understood by the wider pharma organisation, and what can be done?